薬剤比較
Fremanezumab vs Zolmitriptan
Fremanezumab(Ajovy)は片頭痛予防に用いるCGRPモノクローナル抗体であり、Zolmitriptan(Zomig)は急性片頭痛の治療に用いるトリプタン系薬です。作用機序、副作用、使用法を比較します。
このページには比較できる項目がありません。
臨床的背景
Patients with frequent migraines often compare preventive options like Fremanezumab to acute treatments like Zolmitriptan to manage their condition effectively.
結論
Both drugs are effective for migraine but target different aspects—Fremanezumab prevents attacks while Zolmitriptan treats them, making selection based on your specific migraine pattern.
すべての薬剤比較